AI-designed protein shows 50% greater anti-inflammatory effect in animal studies
A research team has developed a next-generation anti-inflammatory protein using AI and supercomputing.
Medical Xpress
Melanoma cancer cells secrete extracellular vesicles to paralyze immune cells
A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds that melanoma cancer cells paralyze immune cells by secreting extracel…
Low-dose peanut therapy shown to protect children with peanut allergies
Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection against peanuts, finds a new study led by The Hospital for Sick Children (SickKids) and Montreal Children’s Hospital.
Researchers turn cancer resistance mutations into targets for new immunotherapies
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant cells acquire mutations that enable them to survive an…
Five new year’s resolutions to help you breathe easier
Making resolutions for the new year?
Blocking a key gene regulator may restore immune response in cancer therapy
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body’s immune system to target tumors. Despite their initial clinical success, many patients eventually experience diminished therapeutic responses as tumors acqui…
Scientists develop targeted therapy for T-cell lymphomas and leukemias
Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established in 2024 for TRBC1-positive tumors.
Study reveals low immunity against H3N2 strain in Hong Kong: Early vaccination urged
Flu activity has surged in many parts of the Northern Hemisphere, driven primarily by a newly emerged H3N2 strain known as subclade K.
TIGIT protein inhibition could help immune system target cancer cells
Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system’s ability to fight cancer, potentially paving the way for new treatments.
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated?